ITCMDBv1
Clinical TrialID 5216

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

NCT00152243

Gastric Cancer

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
5216
Evidence Id
5216
Core Evidence Id
5216
Source Clinical Trial Id
5198
Herb2 Clinical Trial Id
HBCT005198
Nct Id
NCT00152243
Title
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)
Status
Completed
Phase
Phase 3
Study Result
No
Study Condition
Gastric Cancer
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: UFT (uracil, tegafur)|PROCEDURE: Surgery alone
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
500
Outcome Measure
Overall survival and relapse-free survival, every course for first three courses, then every other course
Sponsor Collaborator
Taiho Pharmaceutical Co., Ltd.
Funded By
INDUSTRY
Location
Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6, Ariake, Koto-ku, Tokyo, Japan
Other Id
1023003
Start Date
1997-06
Primary Completion Date
2006-03
Completion Date
2007-08
First Posted
2005-09-09
Results First Posted
Last Update Posted
2011-07-07
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00152243
Title Cn
Title En
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)
Bilingual Status
semi_complete